Ironwood Pharmaceuticals logo
Ironwood Pharmaceuticals IRWD
$ 3.47 3.82%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Ironwood Pharmaceuticals Financial Statements 2011-2024 | IRWD

Annual Financial Statements Ironwood Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

2.28 B 1.76 B 1.81 B 1.63 B 1.87 B 1.7 B 1.93 B 1.71 B 1.1 B 1.79 B 1.4 B 1.15 B 1.24 B

Shares

155 M 154 M 162 M 159 M 154 M 153 M 149 M 146 M 142 M 137 M 116 M 106 M 99.9 M

Historical Prices

14.7 11.4 11.2 10.2 12.1 11.4 12.4 12 7.73 13 11.6 10.7 12.5

Net Income

-1.09 M 48.9 M 528 M 106 M 21.5 M -282 M -117 M -81.7 M -143 M -190 M -273 M -72.6 M -64.9 M

Revenue

118 M 107 M 414 M 390 M 428 M 347 M 298 M 274 M 150 M 76.4 M 22.9 M 150 M 65.9 M

Cost of Revenue

- - - 3.14 M 23.9 M 32.8 M 19.1 M 1.87 M 12 K 25.6 M 7.2 M 965 K -

Gross Profit

- - - - 405 M 314 M 279 M 272 M 150 M 50.9 M 15.7 M 149 M 65.9 M

Operating Income

-945 M 250 M 232 M 143 M 120 M -151 M -15.4 M -51.9 M -102 M -169 M -252 M -72.8 M -66.1 M

Interest Expense

21.6 M 7.6 M 31.2 M 29.5 M 36.6 M 37.7 M 36.4 M 39.2 M 31.1 M 21.2 M 21 M 59 K 63 K

EBITDA

-944 M 252 M 234 M 145 M 123 M -93.9 M -102 M -40.7 M -72.8 M -157 M -240 M -61.4 M -56.1 M

Operating Expenses

- - - - 287 M 416 M 388 M 314 M 234 M 220 M 268 M 222 M 132 M

General and Administrative Expenses

158 M 116 M 111 M 140 M 172 M 241 M 233 M 173 M 125 M 118 M 123 M 92.5 M 45.9 M

All numbers in USD currency

Quarterly Income Statement Ironwood Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

160 M 159 M 158 M 156 M 156 M 155 M 154 M 154 M 153 M 153 M 158 M 162 M 163 M 162 M 161 M 161 M 160 M 159 M 158 M 158 M 156 K 156 K 155 K 154 M 153 K 152 K 151 K - 150 K 149 K 148 K - 145 K 145 K 144 K - 142 K 142 M 141 M - 139 M 138 M 130 M - 121 M 113 M 108 M - 107 M 107 M 104 M - 100 M 99.7 M 99.1 M

Net Income

3.65 M -860 K -4.16 M - 15.3 M -1.06 B 45.7 M - 50.3 M 37.1 M 38.8 M 41.4 M 55.8 M 391 M 39.9 M 43.2 M 34.4 M 25.2 M 3.34 M 47.9 M 20.6 M 12.3 M -59.3 M -15.5 M -174 M -49.4 M -43.1 M 12.1 M -32.3 M -44.2 M -52.5 M -13.5 M -33.2 M -21.7 M -13.3 M -14 M -47.4 M -48 M -33.2 M -37.6 M -42 M -60.4 M -49.6 M -52 M -61.8 M -65.1 M -93.9 M -43.9 M 47.6 M -40.8 M -35.6 M -6.97 M -20.6 M -18.8 M -18.4 M

Revenue

91.6 M 94.4 M 74.9 M - 114 M 107 M 104 M - 109 M 97.2 M 97.5 M 117 M 104 M 104 M 88.8 M 117 M 103 M 89.4 M 79.9 M 126 M 131 M 102 M 68.7 M 131 M 65.7 M 81.1 M 69.2 M 94.2 M 86.8 M 65.1 M 52.2 M 87.5 M 66.1 M 54.4 M 66 M 53.3 M 39.6 M 27.7 M 28.9 M 38.1 M 16.9 M 6.84 M 14.6 M 5.03 M 4.93 M 9.66 M 3.26 M 27 M 96.4 M 14.6 M 12.2 M 32.2 M 12.2 M 11.3 M 10.2 M

Cost of Revenue

- - - - - - - - - - - - - - - - 2.24 M 2.24 M 2.24 M - 506 K 11.3 M 1.04 M - 4.62 M 4.06 M 2.61 M - 6.08 M 3.5 M 531 K - - - - - - 8.15 M 12 K - 3.55 M 10.5 M 1.92 M - 2.02 M 3.42 M 1.23 M - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

25.6 M 25 M 11 M - 40 M -1.08 B 60.1 M - 68.5 M 55.7 M 57.8 M - 65.2 M 65.1 M 45.4 M - 45.6 M 32.7 M 13.2 M - 65.9 M 21.6 M -16.9 M - -147 M -14.7 M -35.9 M - -19.4 M -41 M -39.7 M - -28.3 M -15.3 M -1.97 M - -26.2 M -42 M -28.1 M - -36.7 M -55.1 M -44.4 M - -56.6 M -59.9 M -88.8 M - 47.6 M -40.8 M -35.6 M - -21.6 M -19 M -18.5 M

Interest Expense

- - 7.23 M - 9.84 M 1.84 M 1.53 M - 1.52 M 2.21 M 2.34 M - 7.84 M 7.73 M 7.63 M - 7.42 M 7.32 M 7.22 M - 10.5 M 9.43 M 9.59 M - 9.48 M 9.38 M 9.27 M - 9.14 M 9.05 M 8.98 M - 9.76 M 9.83 M 9.91 M - 10 M 5.87 M 5.22 M - 5.32 M 5.3 M 5.28 M - 5.26 M 5.32 M 5.12 M - 14 K 13 K 14 K - 16 K 17 K 16 K

EBITDA

- - 11.5 M - - - 60.4 M - 69.6 M 55.7 M 58.2 M - 66.3 M 65.1 M 45.8 M - 48.8 M 34 M 13.9 M - 70.6 M 23.1 M -16.2 M - -143 M -12.5 M -34.1 M - -12.8 M -36.2 M -36.8 M 3.3 M -20.8 M -10 M 865 K - -17.4 M -36 M -25.2 M - -27.4 M -48.9 M -41.2 M - -47.9 M -54.3 M -86 M - 56.1 M -35.3 M -33 M - -14.3 M -13.9 M -16.4 M

Operating Expenses

- - - - - - 44 M - 40.2 M - 39.7 M - 38.6 M - 43.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 48.8 M 55.4 M 47.9 M 39.2 M 33.8 M 30.2 M 28.8 M

General and Administrative Expenses

36.1 M 37 M 37.6 M - 36 M 52.5 M 31.1 M - 28.6 M 30.1 M 28.9 M - 27.7 M 27.1 M 27.7 M - 34.9 M 34.6 M 36.4 M - 40.9 M 43.2 M 49.1 M - 50.5 M 59.8 M 59.5 M - 61.8 M 57.8 M 55.6 M - 45 M 36.9 M 36.2 M - 30.4 M 33 M 30.3 M - 28.5 M 29.3 M 29.9 M - 30.3 M 30.9 M 33.4 M - 25.4 M 23.2 M 18.4 M - 10.9 M 10.8 M 9.22 M

All numbers in USD currency